Dr. Kerry Rogers on an Upcoming Phase I Clinical Trial of CDK9 Inhibitor VIP152 for Chronic Lymphocytic Leukemia (CLL) Dr. Brian Koffman spoke with Dr. Kerry Rogers, assistant professor and hematologist in the Division of Hematology at the Ohio... September 7, 2021News, News about Clinical TrialsBy Brad Hedrick
AZD7442 PROVENT Phase III Prophylaxis Trial Met Primary Endpoint in Preventing Symptomatic COVID-19 We still have work to do, but for right now, let’s celebrate this major win for CLL and other immunocompromised... August 20, 2021C19 - Updates, COVID-19, News, News about Clinical TrialsBy Brad Hedrick
Update: 3/26/21: Trials Studying the Safety and Immune Response of Chronic Lymphocytic Leukemia (CLL) Patients Receiving the COVID-19 Vaccines How well CLL (chronic lymphocytic leukemia) patients respond to the SARS-C0V-2 vaccine is the question we are all asking. Fortunately,... February 12, 2021C19 - Updates, COVID-19, News, News about Clinical TrialsBy Brad Hedrick
Vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis Dr. Brian Koffman provides us with a well-referenced video guide to the appropriate use of various types of face masks... November 10, 2020C19 - Updates, COVID-19, News, News about Clinical TrialsBy Brad Hedrick
TG Therapeutics Announces Positive Topline Results TG Therapeutics Announces Positive Topline Results from the UNITY-CLL Phase 3 Study Evaluating the Combination of Umbralisib and Ublituximab (U2)... May 22, 2020News about Clinical TrialsBy Brad Hedrick
It’s Clinical Trials Awareness Week! The CLL Society partners with the nonprofit Coalition for Clinical Trials Awareness to increase trial awareness and participation for CLL... May 18, 2020News about Clinical TrialsBy Brad Hedrick
CAR-T Trial for JCAR017 Now Open at USCD and 27 Other Sites Across the USA An Open-Label, Phase 1/2 Study of JCAR017 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma... October 5, 2019News about Clinical TrialsBy Brad Hedrick
The Transcend 004 Clinical Trial The Transcend CLL 004 Clinical Trial is looking for patients with relapsed or refractory CLL/SLL. The investigational treatment uses a... July 15, 2019News about Clinical TrialsBy Brad Hedrick
A Phase 1/2 Study of Oral LOXO-305 in Patients With Previously Treated CLL A Phase 1/2 Study of Oral LOXO-305 in Patients With Previously Treated CLL offers an option of a novel agent... July 9, 2019News about Clinical TrialsBy Brad Hedrick
High Risk CLL Trial: Q & A Interview with Dr. Adrian Wiestner The National Institutes of Health were founded by Congress in 1887 and charged with being the preeminent research center in... April 27, 2019Clinical Trials, The BasicsBy Brad Hedrick
